Pharmagen Stock Cash And Equivalents
| PHRX Stock | USD 0.00001 0.00 0.00% |
Pharmagen fundamentals help investors to digest information that contributes to Pharmagen's financial success or failures. It also enables traders to predict the movement of Pharmagen Stock. The fundamental analysis module provides a way to measure Pharmagen's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Pharmagen stock.
Pharmagen | Cash And Equivalents |
Pharmagen Company Cash And Equivalents Analysis
Pharmagen's Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
Current Pharmagen Cash And Equivalents | 264.67 K |
Most of Pharmagen's fundamental indicators, such as Cash And Equivalents, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Pharmagen is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Pharmagen Cash And Equivalents Driver Correlations
Understanding the fundamental principles of building solid financial models for Pharmagen is extremely important. It helps to project a fair market value of Pharmagen Stock properly, considering its historical fundamentals such as Cash And Equivalents. Since Pharmagen's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Pharmagen's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Pharmagen's interrelated accounts and indicators.
Click cells to compare fundamentals
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).
| Competition |
In accordance with the recently published financial statements, Pharmagen has 264.67 K in Cash And Equivalents. This is 99.97% lower than that of the Health Care Providers & Services sector and 99.97% lower than that of the Health Care industry. The cash and equivalents for all United States stocks is 99.99% higher than that of the company.
Pharmagen Cash And Equivalents Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Pharmagen's direct or indirect competition against its Cash And Equivalents to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Pharmagen could also be used in its relative valuation, which is a method of valuing Pharmagen by comparing valuation metrics of similar companies.Pharmagen is currently under evaluation in cash and equivalents category among its peers.
Pharmagen Fundamentals
| Return On Asset | -0.59 | ||||
| Profit Margin | (1.33) % | ||||
| Operating Margin | (0.31) % | ||||
| Current Valuation | 5.93 M | ||||
| Shares Outstanding | 517.08 M | ||||
| Price To Earning | (0.06) X | ||||
| Price To Sales | 0.08 X | ||||
| Revenue | 4.81 M | ||||
| Gross Profit | 2.75 M | ||||
| EBITDA | (2.13 M) | ||||
| Net Income | (6 M) | ||||
| Cash And Equivalents | 264.67 K | ||||
| Total Debt | 2.16 M | ||||
| Current Ratio | 0.10 X | ||||
| Book Value Per Share | (0.02) X | ||||
| Cash Flow From Operations | (692.07 K) | ||||
| Target Price | 0.13 | ||||
| Number Of Employees | 24 | ||||
| Beta | 0.028 | ||||
| Market Capitalization | 361.95 K | ||||
| Total Asset | 1.28 M | ||||
| Working Capital | (7.46 M) | ||||
| Current Asset | 837 K | ||||
| Current Liabilities | 8.29 M | ||||
| Net Asset | 1.28 M |
About Pharmagen Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Pharmagen's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Pharmagen using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Pharmagen based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Additional Tools for Pharmagen Stock Analysis
When running Pharmagen's price analysis, check to measure Pharmagen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharmagen is operating at the current time. Most of Pharmagen's value examination focuses on studying past and present price action to predict the probability of Pharmagen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharmagen's price. Additionally, you may evaluate how the addition of Pharmagen to your portfolios can decrease your overall portfolio volatility.